News

Researchers have found that the ABCC4 transporter is critical to the SHH signaling pathway in the brain tumor medulloblastoma – the most common malignant pediatric brain tumor.

A team has developed a method for assembling hanging droplets that could assist chemical reactions in extremely small – less than 1 millimeter – spaces. This new method has potential to be applied to drug manufacturing.

Researchers have engineered a T cell that targets three antigens on the cancer instead of one. Using preclinical models, they then used the modified T cells to target multiple sites on acute lymphoblastic leukemia cells.

Purdue University researchers are working to move COVID-19 diagnostic and therapeutic solutions to the marketplace as soon as possible.

When UC Davis announced the first case of community transmission of COVID-19 in the U.S. on Feb. 26, it solved a medical mystery at the hospital and led to important changes to the U.S. Centers for Disease Control and Prevention (CDC) guidelines for novel coronavirus testing.

Researchers led by biomedical engineers at Tufts University invented a microfluidic chip containing cardiac cells that is capable of mimicking hypoxic conditions following a heart attack - specifically when an artery is blocked in the heart and then unblocked after treatment.

A new study showcases the potential of artificial intelligence (AI) for analyzing brain images during stroke. The process of lesion segmentation normally involves manual analysis by expert radiologists, but new techniques could speed up the analysis.

A first-of-its-kind trial has demonstrated that a receptor involved in the brain’s reward system may be a viable target for treating anhedonia (or lack of pleasure), a key symptom of several mood and anxiety disorders. This innovative fast-fail trial was funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health, and the results of the trial are published in Nature Medicine.

Researchers report that intravenous transplantation of human mesenchymal stem cells appears to be safe and effective for treatment in seven patients with COVID-19 pneumonia.

In a new article published online ahead of print in Cancer Research, scientists report the identification of potential therapeutic targets for cutaneous squamous cell carcinoma.